Skip to main content
BRIDGE: Brain Research - Inter Disciplinary Guided Excellence

Morten Meyer

Phone: +45 2513 8637

E-mail: mmeyer@health.sdu.dk

Department:

Neurobiology Research, Department of Molecular Medicine

Biography:

Morten Meyer is a stem cell researcher and Professor of Experimental Neurobiology. Since 2023, he has served as the Head of Research at the Neurobiology Research Unit, Department of Molecular Medicine, at the University of Southern Denmark. His research primarily focuses on the use of stem cells to investigate the molecular mechanisms underlying neurodegenerative diseases, particularly Parkinson's disease and other synucleinopathies. In addition to his academic role at SDU, he has been affiliated with the Department of Neurology at Odense University Hospital as a guest researcher since 2000. His research integrates cutting-edge stem cell models to study disease mechanisms and explore potential therapeutic strategies for neurodegenerative disorders.

1995: B.Sc. in molecular cell biology, Odense University, DK.

1997: M.Sc. in molecular cell biology, Odense University, DK.

2001: Ph.D. in experimental medical neurobiology, Odense University, DK.

 

1995-97: Research Assistant, Dept. of Neurosurgery Research, University Hospital of Berne, CH.

1997-01: PhD fellow, Anatomy and Neurobiology, Inst. of Medical Biology, University of Southern Denmark, DK.

2001-04: Assistant Professor, Anatomy and Neurobiology, Inst. of Medical Biology, University of Southern Denmark, DK.

2004-2021: Associate Professor, Neurobiology Research Unit, Dept. of Molecular Medicine, University of Southern Denmark, DK.

2020-present: Affiliated as guest researcher at Department of Neurology, Odense University Hospital, Odense, DK.

2021-present: Professor (full), Neurobiology Research Unit, Dept. of Molecular Medicine, University of Southern Denmark, DK.

2023-present:  Head of Research. Neurobiology Research Unit, Dept. of Molecular Medicine, University of Southern Denmark, DK



Investigation of the early cellular changes that underlie the onset of neurodegeneration in Parkinson’s disease (PD) using genetically engineered and patient-derived induced pluripotent stem cells (iPS cells).

Identification and validation of potential molecular disease modifying targets in PD.

Neurotrophic factors, cell replacement and gene-based therapeutic strategies for PD.

Role of environmental toxins in neurodevelopment and PD






Last Updated 28.05.2025